Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that it will report its results for the first quarter of 2014 on Wednesday, May 7, 2014. The company will also hold a live investor conference call and webcast at 10:00am Eastern/7:00am Pacific. Nanosphere, Inc. (NASDAQ:NSPH), shares after opening at $1.76 moved to $1.80 on last trade day and at the end of the day closed at $1.67. Company price to sales ratio in past twelve months was calculated as 12.84 and price to cash ratio as 3.09. Nanosphere, Inc. (NASDAQ:NSPH), showed a negative weekly performance of 10.70%.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI), lost more than two-thirds of its market value, or $1.6 billion, last year after Phase I data presented at the June 2013 ASCO meeting revealed toxicity issues with use of its lead asset, IPI-145, in blood cancer patients. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), shares advanced 0.21% in last trading session and ended the day on $9.36. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), return on equity ratio is recorded as -51.70% and its return on assets is -46.40%. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), yearly performance is -78.88%.
Fibrocell Science Inc (NYSEMKT:FCSC), shares moved down 9.11% in last trading session and was closed at $3.49, while trading in range of $ 3.26 – 4.01. Fibrocell Science Inc (NYSEMKT:FCSC), year to date (YTD) performance is -14.04%.
On April 22,2014, The Shareholders Foundation announces that an investigation on behalf of investors in shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), was announced over potential breaches of fiduciary duties that caused damages to the company and NASDAQ:AVEO stockholders. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), weekly performance is -6.77%. On last trading day company shares ended up $1.24. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), distance from 50-day simple moving average (SMA50) is -24.94%. Analysts mean target Price for the company is $2.50.
Leave a Reply